To contribute to international health technology assessment and reimbursement research standards and methods, and create a forum for communication between researchers, payers and the scientific and academic communities at large.
In the development of evidence in the form of pharmacoeconomic (economic) and outcomes research studies, understanding the use of this evidence is critical in the design of outcomes research studies. However, few outcomes researchers consider the end use of the results when designing the study. It is important that outcomes researchers consider reimbursement guidelines/ protocols in the design and implementation of outcomes research studies and understand the decision-making process.
It is equally important that health care decision makers are knowledgeable of outcomes research methods and use of outcomes research study results in health care decisions. By its presence or absence, reimbursement for a new procedure, drug or medical device can dramatically affect patient care.
If you would like to submit a proposal for a working group initiative, please send an email to: email@example.com
MARKET ACCESS CHALLENGES FOR IN VITRO DIAGNOSTICS: SIMILARITIES AND DIFFERENCES BETWEEN US AND EUROPEAN MARKET
May 2013 – ISPOR 18th Annual International Meeting, ISPOR Forum Presentation, New Orleans, LA, USA
INTERNATIONAL PERSPECTIVES ON CHANGING EVIDENCE REQUIREMENTS FOR MEDICAL DEVICES AND DIAGNOSTICS: ADDRESSING THE MOVING TARGET PROBLEM FOR MEDICAL TECHNOLOGIES
June 2012 – 17th Annual International Meeting, ISPOR Forum Presentation, Washington DC, USA
HTA Of Medical Devices in Europe: Cooperation Between Evaluation Agencies and Implications for Industry
November 2011 – ISPOR 14th Annual European Congress, Issue Panel Presentation, Madrid, Spain
Developing Evidence to Support Reimbursement and Value-Based Pricing: Issues and Challenges for Stand-Alone Versus Companion Diagnostics
May 2011 – ISPOR 16th Annual International Meeting, Forum Presentation, Baltimore, MD, USA
Considerations for Technology Assessments of Diagnostic Product HTA SIG Workshop
November 2010 – ISPOR 13th Annual European Congress, Workshop Presentation, Prague, Czech Republic
Moving Forward With HTA For Medical Devices & Diagnostic Products! The ISPOR Global Health Care Systems Road Map
May 2010 - ISPOR 15th Annual International Meeting, Forum Presentation, Atlanta, GA, USA
How Should HTA Methods Be Adapted to Meet the Rising Expectations of Decision Makers for Medical Devices and Diagnostics Reimbursement?
October 2009 - ISPOR 12th Annual European Congress, Issue Panel Presentation, Paris, Francep
NAVIGATING HEALTH TECHNOLOGY ASSESSMENT PROCESSES AROUND THE WORLD
May 2008 - ISPOR 13th Annual International Meeting Toronto, Canada
Health Technology Assessment (HTA): A Tool for Translating Evidence to Health Policy
May 2007 - ISPOR 12th Annual International ISPOR Meeting
To join this SIG Working Group, see: Join a Special Interest Group.